Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01713946
Brief Title: A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures (EXIST-3)

First Submitted : October 9, 2012
First Submitted that Met QC Criteria : October 22, 2012
First Posted : October 25, 2012 (Estimate)

Results First Submitted : April 25, 2018
Results First Submitted that Met QC Criteria : November 6, 2018
Results First Posted : November 7, 2018

Last Update Submitted that Met QC Criteria : November 6, 2018
Last Update Posted : November 7, 2018